TY - JOUR AU - Cybulski, C. AU - Huzarski, T. AU - Gorski, B. AU - Masojc, B. AU - Mierzejewski, M. AU - Debniak, T. PY - 2004 DA - 2004// TI - A novel founder CHEK2 mutation is associated with increased prostate cancer risk JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-0341 DO - 10.1158/0008-5472.CAN-04-0341 ID - Cybulski2004 ER - TY - JOUR AU - Cybulski, C. AU - Wokolorczyk, D. AU - Jakubowska, A. AU - Huzarski, T. AU - Byrski, T. AU - Gronwald, J. PY - 2011 DA - 2011// TI - Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.34.0778 DO - 10.1200/JCO.2010.34.0778 ID - Cybulski2011 ER - TY - JOUR AU - Meijers-Heijboer, H. AU - Ouweland, A. AU - Klijn, J. AU - Wasielewski, M. AU - Snoo, A. AU - Oldenburg, R. PY - 2002 DA - 2002// TI - Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations JO - Nat Genet VL - 31 UR - https://doi.org/10.1038/ng879 DO - 10.1038/ng879 ID - Meijers-Heijboer2002 ER - TY - JOUR AU - Krivokuca, A. AU - Dobricic, J. AU - Brankovic-Magic, M. PY - 2013 DA - 2013// TI - CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families JO - J BUON VL - 18 ID - Krivokuca2013 ER - TY - JOUR AU - Walsh, T. AU - Casadei, S. AU - Coats, K. H. AU - Swisher, E. AU - Stray, S. M. AU - Higgins, J. PY - 2006 DA - 2006// TI - Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.12.1379 DO - 10.1001/jama.295.12.1379 ID - Walsh2006 ER - TY - JOUR AU - Havranek, O. AU - Kleiblova, P. AU - Hojny, J. AU - Lhota, F. AU - Soucek, P. AU - Trneny, M. PY - 2015 DA - 2015// TI - Association of germline CHEK2 gene variants with risk and prognosis of Non-Hodgkin lymphoma JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0140819 DO - 10.1371/journal.pone.0140819 ID - Havranek2015 ER - TY - JOUR AU - Siolek, M. AU - Cybulski, C. AU - Gasior-Perczak, D. AU - Kowalik, A. AU - Kozak-Klonowska, B. AU - Kowalska, A. PY - 2015 DA - 2015// TI - CHEK2 mutations and the risk of papillary thyroid cancer JO - Int J Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29426 DO - 10.1002/ijc.29426 ID - Siolek2015 ER - TY - JOUR AU - Chrisanthar, R. AU - Knappskog, S. AU - Lokkevik, E. AU - Anker, G. AU - Ostenstad, B. AU - Lundgren, S. PY - 2008 DA - 2008// TI - CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer JO - PLoS ONE VL - 3 UR - https://doi.org/10.1371/journal.pone.0003062 DO - 10.1371/journal.pone.0003062 ID - Chrisanthar2008 ER - TY - JOUR AU - Knappskog, S. AU - Berge, E. O. AU - Chrisanthar, R. AU - Geisler, S. AU - Staalesen, V. AU - Leirvaag, B. PY - 2015 DA - 2015// TI - Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo JO - Mol Oncol VL - 9 UR - https://doi.org/10.1016/j.molonc.2015.04.008 DO - 10.1016/j.molonc.2015.04.008 ID - Knappskog2015 ER - TY - JOUR AU - Knappskog, S. AU - Chrisanthar, R. AU - Lokkevik, E. AU - Anker, G. AU - Ostenstad, B. AU - Lundgren, S. PY - 2012 DA - 2012// TI - Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer JO - Breast Cancer Res VL - 14 UR - https://doi.org/10.1186/bcr3147 DO - 10.1186/bcr3147 ID - Knappskog2012 ER - TY - JOUR AU - Naess, O. AU - Sogaard, A. J. AU - Arnesen, E. AU - Beckstrom, A. C. AU - Bjertness, E. AU - Engeland, A. PY - 2008 DA - 2008// TI - Cohort profile: cohort of Norway (CONOR) JO - Int J Epidemiol VL - 37 UR - https://doi.org/10.1093/ije/dym217 DO - 10.1093/ije/dym217 ID - Naess2008 ER - TY - JOUR AU - Gansmo, L. B. AU - Knappskog, S. AU - Romundstad, P. AU - Hveem, K. AU - Vatten, L. AU - Lonning, P. E. PY - 2015 DA - 2015// TI - Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon JO - Int J Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29358 DO - 10.1002/ijc.29358 ID - Gansmo2015 ER - TY - JOUR AU - Genomes Project, C. AU - Abecasis, G. R. AU - Auton, A. AU - Brooks, L. D. AU - DePristo, M. A. AU - Durbin, R. M. PY - 2012 DA - 2012// TI - An integrated map of genetic variation from 1,092 human genomes JO - Nature VL - 491 UR - https://doi.org/10.1038/nature11632 DO - 10.1038/nature11632 ID - Genomes Project2012 ER - TY - JOUR AU - Huijts, P. E. AU - Hollestelle, A. AU - Balliu, B. AU - Houwing-Duistermaat, J. J. AU - Meijers, C. M. AU - Blom, J. C. PY - 2014 DA - 2014// TI - CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer JO - Eur J Hum Genet VL - 22 UR - https://doi.org/10.1038/ejhg.2013.85 DO - 10.1038/ejhg.2013.85 ID - Huijts2014 ER - TY - JOUR AU - Wang, N. AU - Ding, H. AU - Liu, C. AU - Li, X. AU - Wei, L. AU - Yu, J. PY - 2015 DA - 2015// TI - A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2014.443 DO - 10.1038/onc.2014.443 ID - Wang2015 ER - TY - JOUR AU - Staalesen, V. AU - Falck, J. AU - Geisler, S. AU - Bartkova, J. AU - Borresen-Dale, A. L. AU - Lukas, J. PY - 2004 DA - 2004// TI - Alternative splicing and mutation status of CHEK2 in stage III breast cancer JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1207928 DO - 10.1038/sj.onc.1207928 ID - Staalesen2004 ER -